# Efficacy and Safety Study of Binodenoson in Assessing Cardiac Ischemia

> **NCT00944294** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 419 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** binodenoson
- **DRUG:** adenosine

## Key facts

- **NCT ID:** NCT00944294
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2006-04
- **Final completion:** 2006-04
- **Target enrollment:** 419 (ACTUAL)
- **Last updated:** 2012-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00944294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00944294, "Efficacy and Safety Study of Binodenoson in Assessing Cardiac Ischemia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00944294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*